Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2014
02/12/2014CN103570715A Salt of uncaria alkaloid derivative
02/12/2014CN103570714A Synthon and method for preparing dibenzocoronene compounds by same
02/12/2014CN103570713A Polymerizable perylene bisimide photoelectric acceptor material and synthetic method thereof
02/12/2014CN103570712A Phosphorescent compound and OLED using the same
02/12/2014CN103570711A Pyronaridine compounds and applications thereof
02/12/2014CN103570710A Praziquantel preparation process
02/12/2014CN103570709A Pyrazolopyridine compounds, preparation method, uses and drug composition thereof
02/12/2014CN103570695A Preparation of icaritin and derivatives thereof and application of icaritin and derivatives of icaritin in radiotherapy
02/12/2014CN103570694A Preparation of icaritin and derivatives thereof and application of icaritin and derivatives of icaritin in tumor treatment
02/12/2014CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines
02/12/2014CN103570683A Multi-substituted amine compound, as well as preparation method and use thereof
02/12/2014CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines
02/12/2014CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof
02/11/2014US8648194 Compounds having phenanthroline structure
02/11/2014US8648110 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
02/11/2014US8648092 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
02/11/2014US8648076 Cysteine protease inhibitors and their therapeutic applications
02/11/2014CA2778291C Akt inhibitors
02/11/2014CA2755285C Inhibitors of pi3 kinase
02/11/2014CA2738563C 8-substituted isoquinoline derivatives and the use thereof
02/11/2014CA2717246C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
02/11/2014CA2685215C Compounds and methods useful for treating asthma and allergic inflammation
02/11/2014CA2650954C Bicyclic derivatives as cetp inhibitors
02/11/2014CA2618110C Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
02/11/2014CA2599643C Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
02/11/2014CA2572121C Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
02/11/2014CA2536622C Inhibitors of cellular necrosis
02/11/2014CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
02/06/2014WO2014022767A1 Dihydropyridone p1 as factor xia inhibitors
02/06/2014WO2014022766A1 Dihydropyridone p1 as factor xia inhibitors
02/06/2014WO2014022752A1 Macrocycles as pim inhibitors
02/06/2014WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
02/06/2014WO2014022349A1 7-hydroxy-spiropipiperidine indolinyl antagonists of p2y1 receptor
02/06/2014WO2014022253A1 Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of p2y1 receptor
02/06/2014WO2014022167A1 Aryl lactam kinase inhibitors
02/06/2014WO2014021383A1 Condensed ring heterocyclic compound
02/06/2014WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound
02/06/2014WO2014020405A1 Cyclic urea- or lactam-substituted quinoxaline-type piperidine compounds and the uses thereof
02/06/2014WO2014019979A1 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
02/06/2014US20140039002 Solid forms of a pharmaceutically active substance
02/06/2014US20140038999 Aryl Lactam Kinase Inhibitors
02/06/2014US20140038991 Protein Kinase Inhibitors
02/06/2014US20140038980 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
02/06/2014US20140038976 Piperazine derivatives as cav2.2 calcium channel blockers
02/06/2014US20140038969 Dihydropyridone p1 as factor xia inhibitors
02/06/2014US20140038960 Hetaryl-[1,8]naphthyridine derivatives
02/06/2014US20140038956 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc).
02/06/2014US20140038955 Heteroaryl amide analogues as p2x7 antagonists
02/06/2014US20140038953 Compositions and methods for cardiovascular disease
02/06/2014US20140038952 Substituted Amino-Pyrimidine Derivatives
02/06/2014US20140038948 Compounds and methods for kinase modulation, and indications therefor
02/06/2014US20140038946 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
02/06/2014US20140038943 Serotonin receptor modulator
02/06/2014US20140038942 RORgammaT INHIBITORS
02/06/2014US20140038941 Ring-fused heterocyclic derivative
02/06/2014US20140038936 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
02/06/2014US20140038926 Heteroaryl-Ketone Fused Azadecalin Glucocorticoid Receptor Modulators
02/06/2014US20140038922 Wnt protein signalling inhibitors
02/06/2014US20140038919 Hepatitis c inhibitors and uses thereof
02/06/2014US20140037617 Kinase modulation, and indications therefor
02/05/2014EP2692728A1 Novel furanone derivative
02/05/2014EP2691394A1 Compounds for treatment of metabolic syndrome
02/05/2014EP2691393A1 Novel bicyclic pyridinones
02/05/2014EP2691392A1 Imidazo [1,2-a]pyridine compounds for use in therapy
02/05/2014CN103562206A 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
02/05/2014CN103562205A Inhibitors of influenza viruses replication
02/05/2014CN103562191A Nitrogen-containing saturated heterocyclic compound
02/05/2014CN103562180A New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
02/05/2014CN103555322A Novel organic electroluminescent compounds and organic electroluminescent device using same
02/05/2014CN103554309A Resin for separating and purifying tabersonine and applications thereof
02/05/2014CN103554112A Synthetic method of beta-lactam compound with cis condensed ring
02/05/2014CN103554108A Improved tadalafil preparation method
02/05/2014CN103554107A Azaadamantane derivatives and methods of use
02/05/2014CN103554106A Amino/amine oxide modified perylene diimide derivative as well as preparation method and application thereof
02/05/2014CN103554105A 9-hydroxyl risperidone purifying method
02/05/2014CN103554104A Azaindoles useful as inhibitors of jak and other protein kinases
02/05/2014CN103554103A Indole[3,2-c]quinoline compounds or pharmaceutically acceptable salts thereof, and preparation method and application thereof
02/05/2014CN103554023A Synthesis method of acridine derivative and synthesized polycyclic acridine derivative
02/05/2014CN103554011A Anthracene containing derivative as well as preparation method and application thereof
02/04/2014US8642765 Azaindole-indole coupled derivatives, preparation methods and uses thereof
02/04/2014US8642624 Substituted alkylamine derivatives and methods of use
02/04/2014US8642610 Dual small molecule inhibitors of cancer and angiogenesis
02/04/2014US8642609 Modulators of ATP-binding cassette transporters
02/04/2014US8642601 Inhibitors of JNK
02/04/2014US8642587 Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
02/04/2014CA2607426C Fused thiazole derivatives as kinase inhibitors
02/04/2014CA2491191C Receptor-type kinase modulators and methods of use
01/2014
01/30/2014WO2014018764A1 Spiro - fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel
01/30/2014WO2014018449A1 Substituted naphthyridinedione derivatives as hiv integrase inhibitors
01/30/2014WO2014017643A1 Difluoromethylene compound
01/30/2014WO2014017569A1 Pharmaceutical product for lowering blood ldl
01/30/2014WO2014017087A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
01/30/2014WO2014017042A1 Film-forming organic material, organic photoelectric conversion element obtained using same, imaging element, film-forming method, and method for manufacturing organic photoelectric conversion element
01/30/2014WO2014015993A1 Bicyclic aza-amides for treatment of psychiatric disorders
01/30/2014WO2014015905A1 2 - (azaindol- 2 -yl) benz imidazoles as pad4 inhibitors
01/30/2014WO2014015523A1 Novel heteroaryl and heterocycle compounds, compositions and methods
01/30/2014WO2014015495A1 Inhibitors of the renal outer medullary potassium channel
01/30/2014WO2013083611A3 Ring-bridged anthraquinone dye for dyeing keratinous fibres
01/30/2014US20140031551 Purified Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions and Methods for Preparing and Using Same
01/30/2014US20140031549 Process and Intermediates for the Synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 646